FDA

FDA Public Meeting/Webinar on FSMA Preventive Controls Final Rules (and Beyond)

FDA has scheduled a public meeting in Chicago on Tuesday, October 20, 2015, from 8:30 a.m. until 5 p.m., (Central), as a follow-up to its recent publication of final rules establishing preventive controls requirements for human and animal foods.  The public meeting will be broadcast as a live webinar, too.    It is intended to provide

FDA Public Meeting/Webinar on FSMA Preventive Controls Final Rules (and Beyond) Read More »

New York City Does It Again, Requiring a High Sodium Warning

  Just when you thought FDA menu labeling requirements were final and had preempted state and local laws, New York City’s (NYC) Board of Health approved on September 9 a new sodium warning label. The new law requires “covered establishments” (including restaurants with 15 or more locations nationally, doing business under the same name and

New York City Does It Again, Requiring a High Sodium Warning Read More »

FDA Notice Provides a “Backdoor” for Commenting on GRAS Notification Program

The U.S. Food and Drug Administration (FDA) today published a Federal Register Notice soliciting comments on its GRAS Notification (GRASN) Program.  “GRAS” is an acronym for the phrase “generally recognized as safe.” Under sections 201(s) and 409 of the FD&C Act, any substance that is intentionally added to food is a food additive, which is

FDA Notice Provides a “Backdoor” for Commenting on GRAS Notification Program Read More »

FDA Releases Two FSMA Final Rules: Preventive Controls for Human Food and Preventive Controls for Animal Food

The Food and Drug Administration (FDA) has released two major, final rules to implement the FDA Food Safety Modernization Act (FSMA). The final rules are: Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Human Food; and Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Food for Animals.

FDA Releases Two FSMA Final Rules: Preventive Controls for Human Food and Preventive Controls for Animal Food Read More »

FDA Extends Comment Period on Nutrition Labeling Reforms

In tomorrow’s Federal Register, FDA will publish a notice extending until October 13, 2015, the comment period on its proposed changes to the Nutrition Facts and Supplement Facts panels used in labeling conventional foods and dietary supplements.  In connection with this comment period extension, the agency has placed additional documents in the docket, and will

FDA Extends Comment Period on Nutrition Labeling Reforms Read More »

EPA Hazardous Waste Pharmaceuticals Rule Begins Circulating: Proposal Applies To Dietary Supplements, 503B Outsourcing Facilities, And Any OTC Retailers

On Tuesday, the Environmental Protection Agency (EPA) announced that its Administrator signed the proposed rule: Management Standards for Hazardous Waste Pharmaceuticals Rule.  The announcement and EPA blog post are here.   The summary of the pre-publication proposed rule is available here and the 267-page proposal is available for download here.  EPA is expected to publish the

EPA Hazardous Waste Pharmaceuticals Rule Begins Circulating: Proposal Applies To Dietary Supplements, 503B Outsourcing Facilities, And Any OTC Retailers Read More »

OFW’s Bruce Silverglade to Participate at FDLI Food Advertising and Litigation Conference

OFW Law’s Bruce Silverglade will be a featured speaker at that Food and Drug Law Institute’s annual “Food Advertising and Litigation” conference on September 24, 2015, in Chicago, Illinois.  Mr. Silverglade will participate in a panel discussing “Advertising and Labeling Trends and the Next ‘Natural.’” The conference takes place against a backdrop of approximately 200

OFW’s Bruce Silverglade to Participate at FDLI Food Advertising and Litigation Conference Read More »

John Block: Raw Milk

By John R. Block “Got raw milk?  Well, don’t drink it! …Too many people are risking their health and the health of their children unnecessarily.” Those are the words of Dr. Richard Raymond, former U.S. Department of Agriculture Under Secretary for food safety.  His opinion piece in Feedstuffs Magazine sounds the alarm. Turn back the clock

John Block: Raw Milk Read More »

Five Unresolved Questions the Food Industry Should Be Looking for Answers to in FDA’s Final FSMA Regulations

It’s August, which in Washington means Congress recesses, the President and much of the bureaucracy go on vacation and the wheels of government move more slowly than usual. However, that slower pace is going to be short-lived for the food industry. On or about August 30, just two weeks from now, FDA, under court ordered

Five Unresolved Questions the Food Industry Should Be Looking for Answers to in FDA’s Final FSMA Regulations Read More »

The Agriculture Biotechnology Riddle

The debate over agriculture biotechnology (aka genetic engineering (GE), genetic modification (GM), and GM organisms (GMOs)) was front and center in July. First, the White House issued an Executive Memorandum (“the Memorandum”) entitled “Modernizing the Regulatory System for Biotechnology Products.”  The Memorandum, issued by the White House Office of Science and Technology Policy and Council

The Agriculture Biotechnology Riddle Read More »

Declaring Small Amounts of Nutrients and Dietary Ingredients on Nutrition Labels

FDA has published Federal Register notice of a draft guidance document, entitled “FDA’s Policy on Declaring Small Amounts of Nutrients and Dietary Ingredients on Nutrition Labels: Guidance for Industry” (July 2015). Issuance of the draft guidance for industry was deemed necessary because declaring small amounts of nutrients and dietary ingredients in the nutrition labeling of,

Declaring Small Amounts of Nutrients and Dietary Ingredients on Nutrition Labels Read More »

Are You Ready for Electronic MDR Reporting?

Paper medical device reports (MDR) will soon be a thing of the past.  On August 14, 2015, the electronic MDR final rule goes into effect, requiring manufacturers, importers and other firms responsible for reporting to submit MDRs to the FDA electronically through the agency’s Electronic Submission Gateway (ESG) rather than through paper forms, including discs or facsimiles. As detailed in FDA’s February 13, 2014, final rule on Electronic Medical

Are You Ready for Electronic MDR Reporting? Read More »

John Block Reports: Let’s Keep A Strong Alcohol Section in the 2015 Dietary Guidelines

OFW Law founding principal Richard L. Frank fills in for former USDA Secretary John R. Block: Today’s Quiz: What has more alcohol – a 12 oz can of beer? A 5 oz glass of wine? Or, a mixed drink with 1.5 oz of spirits? Answer – they all have the same amount of alcohol. 0.6 fl oz. With

John Block Reports: Let’s Keep A Strong Alcohol Section in the 2015 Dietary Guidelines Read More »

The White House Announces Plans to Update the U.S. Regulatory Framework for Biotechnology

On July 2nd, the White House issued an executive memorandum on “Modernizing the Regulatory System for Biotechnology Products.”  The modernization effort will apply to “biotechnology products” defined as “products developed through genetic engineering or the targeted or in vitro manipulation of genetic information of organisms, including plants, animals, and microbes.”  It will not affect regulation

The White House Announces Plans to Update the U.S. Regulatory Framework for Biotechnology Read More »

Doom and Gloom: FSIS Provides Recommendations to Retailers on Listeria Control

The Food Safety and Inspection Service (FSIS) has authority under the Federal Meat and Poultry Products Inspection Acts to ensure that products are not adulterated at retail and at all steps in the distribution chain. Retail operations are generally inspected by State or local authorities which have adopted some form of the model Food Code

Doom and Gloom: FSIS Provides Recommendations to Retailers on Listeria Control Read More »

Device Firms: What You Should Know About The 21st Century Cures Act

Last month, legislation that would affect, among other things, FDA’s regulation of medical devices and the manufacturers of such devices took a considerable step forward when it was introduced and then unanimously approved by the House Energy and Commerce Committee by a vote of 51-0 on May 21.  Known as the 21st Century Cures Act (“Act”),

Device Firms: What You Should Know About The 21st Century Cures Act Read More »

FDA Releases Draft Guidance on Compounding Animal Drugs

Yesterday, FDA released a Draft Guidance for Industry on Compounding Animal Drugs from Bulk Drug Substances (Draft Guidance).  The Federal Register notice accompanying the Draft Guidance can be found here.  The agency also withdrew its previous Compliance Policy Guide (CPG) 608.400, Compounding of Drugs for Use in Animals. Though FDA has been actively implementing Title

FDA Releases Draft Guidance on Compounding Animal Drugs Read More »

Clearing Up Confusion: The Net Quantity of Contents Declaration on Food Labels

By Robert A. Hahn The FDA’s food labeling regulations include some traps for the unwary.  A few of those traps have to do with the net quantity of contents declaration. Here are a couple of points to keep in mind when declaring a food product’s net contents: When the net contents declaration is expressed in terms

Clearing Up Confusion: The Net Quantity of Contents Declaration on Food Labels Read More »

Food Defense Plans

By Barbara J. Masters, D.V.M. One of the goals of the Food Safety and Inspection Service’s Strategic Plan is to “ensure that facilities implement safeguards and systems to protect food from contamination by people who might try to intentionally and maliciously harm consumers.”  The Agency has a FY 2015 target of 90% of all establishments having a

Food Defense Plans Read More »

FDA Provides Another Guidance Concerning FDA’s Use of Foreign Study Data

By Mason Weeda FDA’s Center for Devices and Radiological Health (“CDRH”) and Center Biologics Evaluation and Research (“CBER”) recently published a new draft guidance entitled “Acceptance of Medical Device Clinical Data from Studies Conducted Outside the United States [(“OUS”)] (“Draft Guidance”) (available here). With this Draft Guidance, FDA aims to minimize the possibility for additional

FDA Provides Another Guidance Concerning FDA’s Use of Foreign Study Data Read More »